ARTICLE | Financial News
Protagonist Therapeutics completes IPO
August 15, 2016 7:00 AM UTC
Protagonist Therapeutics Inc. (NASDAQ:PTGX), Milpitas, Calif. Business: Autoimmune, Inflammation Date completed: 2016-08-10 Type: IPO Raised: $90 million Shares: 7.5 million Price: $12 Shares after of...